ORMP Annual Accounts Payable
$551.00 K
-$1.62 M-74.67%
01 December 2023
Summary:
As of January 23, 2025, ORMP annual accounts payable is $551.00 thousand, with the most recent change of -$1.62 million (-74.67%) on December 1, 2023. ORMP annual accounts payable is now -78.86% below its all-time high of $2.61 million, reached on August 31, 2021.ORMP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORMP Quarterly Accounts Payable
$5.00 M
+$1.51 M+43.41%
01 September 2024
Summary:
As of January 23, 2025, ORMP quarterly accounts payable is $5.00 million, with the most recent change of +$1.51 million (+43.41%) on September 1, 2024. Over the past year, it has increased by +$4.44 million (+806.53%). ORMP quarterly accounts payable is now at all-time high.ORMP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORMP Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.7% | +806.5% |
| 3 y3 years | - | +43.5% |
| 5 y5 years | -58.8% | +273.6% |
ORMP Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.7% | at low | at high | +806.5% |
| 5 y | 5-year | -78.9% | at low | at high | +806.5% |
| alltime | all time | -78.9% | +9739.3% | at high | >+9999.0% |
Oramed Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.00 M(+43.4%) |
| June 2024 | - | $3.48 M(+174.9%) |
| Mar 2024 | - | $1.27 M(+129.9%) |
| Dec 2023 | $551.00 K(-74.7%) | $551.00 K(-78.5%) |
| Sept 2023 | - | $2.56 M(+209.3%) |
| June 2023 | - | $828.00 K(-79.6%) |
| Mar 2023 | - | $4.05 M(+86.4%) |
| Dec 2022 | $2.17 M(+28.5%) | $2.17 M(-48.3%) |
| Sept 2022 | - | $4.21 M(+20.8%) |
| June 2022 | - | $3.48 M(+5.2%) |
| Mar 2022 | - | $3.31 M(-30.5%) |
| Dec 2021 | $1.69 M(-35.1%) | - |
| Nov 2021 | - | $4.76 M(+82.7%) |
| Aug 2021 | $2.61 M(+338.7%) | $2.61 M(-8.9%) |
| May 2021 | - | $2.86 M(-4.8%) |
| Feb 2021 | - | $3.00 M(+6.9%) |
| Nov 2020 | - | $2.81 M(+372.7%) |
| Aug 2020 | $594.00 K(-55.6%) | $594.00 K(-56.0%) |
| May 2020 | - | $1.35 M(-43.2%) |
| Feb 2020 | - | $2.38 M(+32.3%) |
| Nov 2019 | - | $1.80 M(+34.3%) |
| Aug 2019 | $1.34 M(+17.8%) | $1.34 M(-46.0%) |
| May 2019 | - | $2.47 M(+5.5%) |
| Feb 2019 | - | $2.35 M(-21.3%) |
| Nov 2018 | - | $2.98 M(+162.7%) |
| Aug 2018 | $1.14 M(+98.8%) | $1.14 M(-63.9%) |
| May 2018 | - | $3.14 M(+45.8%) |
| Feb 2018 | - | $2.16 M(+36.3%) |
| Nov 2017 | - | $1.58 M(+177.1%) |
| Aug 2017 | $571.00 K(+56.4%) | $571.00 K(-77.4%) |
| May 2017 | - | $2.53 M(+4.2%) |
| Feb 2017 | - | $2.42 M(+8.4%) |
| Nov 2016 | - | $2.24 M(+512.9%) |
| Aug 2016 | $365.00 K(-61.7%) | $365.00 K(-43.5%) |
| May 2016 | - | $646.00 K(-22.1%) |
| Feb 2016 | - | $829.00 K(+7.9%) |
| Nov 2015 | - | $768.00 K(-19.4%) |
| Aug 2015 | $953.00 K | $953.00 K(+30.4%) |
| May 2015 | - | $731.00 K(+28.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $570.00 K(-28.3%) |
| Nov 2014 | - | $795.00 K(-14.1%) |
| Aug 2014 | $926.00 K(+113.4%) | $926.00 K(+87.1%) |
| May 2014 | - | $495.00 K(+41.5%) |
| Feb 2014 | - | $349.80 K(-47.7%) |
| Nov 2013 | - | $668.50 K(+54.0%) |
| Aug 2013 | $434.00 K(-30.9%) | $434.00 K(-2.7%) |
| May 2013 | - | $446.00 K(-5.0%) |
| Feb 2013 | - | $469.40 K(+892.4%) |
| Nov 2012 | - | $47.30 K(-92.5%) |
| Aug 2012 | $628.00 K(+1227.7%) | $628.00 K(+1227.7%) |
| May 2012 | - | $47.30 K(0.0%) |
| Feb 2012 | - | $47.30 K(0.0%) |
| Nov 2011 | - | $47.30 K(0.0%) |
| Aug 2011 | $47.30 K(0.0%) | $47.30 K(0.0%) |
| May 2011 | - | $47.30 K(0.0%) |
| Feb 2011 | - | $47.30 K(0.0%) |
| Nov 2010 | - | $47.30 K(0.0%) |
| Aug 2010 | $47.30 K(0.0%) | $47.30 K(-83.5%) |
| May 2010 | - | $286.30 K(+1.4%) |
| Feb 2010 | - | $282.40 K(+497.0%) |
| Nov 2009 | - | $47.30 K(0.0%) |
| Aug 2009 | $47.30 K(-94.8%) | $47.30 K(0.0%) |
| May 2009 | - | $47.30 K(-91.3%) |
| Feb 2009 | - | $543.80 K(-17.6%) |
| Nov 2008 | - | $660.20 K(-27.8%) |
| Aug 2008 | $914.00 K(+168.0%) | $914.00 K(+187.4%) |
| May 2008 | - | $318.00 K(+101.3%) |
| Feb 2008 | - | $158.00 K(+135.8%) |
| Nov 2007 | - | $67.00 K(-80.4%) |
| Aug 2007 | $341.00 K(+535.0%) | $341.00 K(+3086.9%) |
| May 2007 | - | $10.70 K(-71.5%) |
| Feb 2007 | - | $37.60 K(+203.2%) |
| Nov 2006 | - | $12.40 K(-76.9%) |
| Aug 2006 | $53.70 K(+858.9%) | $53.70 K(+162.0%) |
| May 2006 | - | $20.50 K(+388.1%) |
| Feb 2006 | - | $4200.00(+5.0%) |
| Nov 2005 | - | $4000.00 |
| Aug 2005 | $5600.00 | - |
FAQ
- What is Oramed Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual accounts payable year-on-year change?
- What is Oramed Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly accounts payable year-on-year change?
What is Oramed Pharmaceuticals annual accounts payable?
The current annual accounts payable of ORMP is $551.00 K
What is the all time high annual accounts payable for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual accounts payable is $2.61 M
What is Oramed Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ORMP annual accounts payable has changed by -$1.62 M (-74.67%)
What is Oramed Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ORMP is $5.00 M
What is the all time high quarterly accounts payable for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly accounts payable is $5.00 M
What is Oramed Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ORMP quarterly accounts payable has changed by +$4.44 M (+806.53%)